Q4 2024 iRhythm Technologies Inc Earnings Call Transcript
Key Points
- iRhythm Technologies Inc (IRTC) achieved over 20% revenue growth in 2024, driven by sustained volume demand across all customer channels.
- The company celebrated 1 million patients registered for GeoMonitor in 2024, highlighting strong adoption of their new long-term continuous monitor.
- iRhythm Technologies Inc (IRTC) improved its gross margin profile from 66% at the beginning of the year to 70% by the fourth quarter of 2024.
- The company successfully expanded its international presence, launching ZO services in Austria, the Netherlands, Switzerland, and Spain, and received regulatory approval in Japan.
- iRhythm Technologies Inc (IRTC) reported its first positive adjusted net income in the fourth quarter of 2024, demonstrating a focus on profitable growth.
- The company faces potential tariffs from Mexico, Canada, and China, which could negatively impact gross margins by 50 to 75 basis points.
- iRhythm Technologies Inc (IRTC) continues to incur significant expenses related to FDA remediation efforts and DOJ subpoena activities, totaling approximately $11 million in 2024.
- There is a low single-digit pricing pressure expected in 2025, which could impact revenue growth.
- The company is still in the early stages of international expansion, with contributions from new markets expected to be modest in 2025.
- iRhythm Technologies Inc (IRTC) is managing ongoing regulatory and quality compliance issues, with remediation efforts expected to continue throughout 2025.
Good afternoon.
Thank you for attending today's iRhythm technologies Q4 2024 earnings conference call. My name is Cole, and I'll be the moderator for today's call. All lines will be muted during the presentation portion of the call with an opportunity for questions and answers at the end.
If you'd like to queue for a question, you can do so by pressing one on your telephone keypad.
I'd now like to turn it over to Stephanie Zhadkevich. Please go ahead.
Thank you all for participating in today's call. Earlier today, IRhythm released financial results for the 4th quarter and full year ended December 31, 2024.
Before we begin, I'd like to remind you that management will make statements during this call that include forward-looking statements within the meaning of federal security laws pursuant to the state harbor provisions of the Private Securities Litigation Reform Act of 1,995. Any statements contained in this call that are not statements of
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
